Apple removed a feature on their watch that can measure blood oxygen level because another company said they have the right to use it and didn't want them to sell it. This might make it harder for people with sleep apnea, a condition where they stop breathing while asleep, to be detected by their watch. The boss of the other company thinks that Apple's watch users are better off without this feature because he believes it is not very accurate and can cause more harm than good. Read from source...

- The article is poorly written and lacks clarity. It mixes different topics without proper structure or coherence, such as the import ban, the patent dispute, the blood oxygen feature, and sleep apnea detection.
- The article relies on a single source for most of its information, Mark Gurman, who is not an expert in health or medical devices, but a journalist and a frequent rumor monger about Apple's products. His opinion should be taken with caution and verified by other credible sources.
- The article quotes Joe Kiani, the CEO of Masimo Corp., who has a clear conflict of interest and an axe to grind against Apple. He is suing Apple for patent infringement over the blood oxygen sensor, which he claims is unreliable and misleading consumers. His statement is biased and self-serving, and does not provide any evidence or data to support his claim.
- The article uses emotional language and exaggerates the impact of the blood oxygen feature on Apple Watch users' health and wellness. It implies that without the feature, users are better off and safer, which is not necessarily true. It also suggests that Apple is deceiving consumers and putting them at risk, which is a serious accusation that requires solid proof, not speculation or hearsay.
- The article does not address the possible benefits or advantages of the blood oxygen feature, such as its accuracy, convenience, integration with other health apps and services, or user feedback and reviews. It also does not mention any alternative solutions or options for users who want to monitor their blood oxygen levels, such as external devices or competing products from other brands.